246 related articles for article (PubMed ID: 35966076)
1. 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.
Chu JL; Bi SH; He Y; Ma RY; Wan XY; Wang ZH; Zhang L; Zheng MZ; Yang ZQ; Du LW; Maimaiti Y; Biekedawulaiti G; Duolikun M; Chen HY; Chen L; Li LL; Tie L; Lin J
Front Endocrinol (Lausanne); 2022; 13():910907. PubMed ID: 35966076
[TBL] [Abstract][Full Text] [Related]
2. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
Chen J; Luo SF; Yuan X; Wang M; Yu HJ; Zhang Z; Yang YY
J Cell Biochem; 2022 Feb; 123(2):481-492. PubMed ID: 34908186
[TBL] [Abstract][Full Text] [Related]
3. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
Beadell AV; Zhang Z; Capuano AW; Bennett DA; He C; Zhang W; Arvanitakis Z
J Alzheimers Dis; 2023; 93(3):1135-1151. PubMed ID: 37182870
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes in diabetic kidney disease via multiple-microarray analysis.
Zhang Y; Li W; Zhou Y
Ann Transl Med; 2020 Aug; 8(16):997. PubMed ID: 32953797
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
Zhang X; Chao P; Zhang L; Xu L; Cui X; Wang S; Wusiman M; Jiang H; Lu C
Front Immunol; 2023; 14():1030198. PubMed ID: 37063851
[TBL] [Abstract][Full Text] [Related]
7. FN1 and TGFBI are key biomarkers of macrophage immune injury in diabetic kidney disease.
Dou F; Liu Q; Lv S; Xu Q; Wang X; Liu S; Liu G
Medicine (Baltimore); 2023 Nov; 102(45):e35794. PubMed ID: 37960829
[TBL] [Abstract][Full Text] [Related]
8. Identification and analysis of cellular senescence-associated signatures in diabetic kidney disease by integrated bioinformatics analysis and machine learning.
Luo Y; Zhang L; Zhao T
Front Endocrinol (Lausanne); 2023; 14():1193228. PubMed ID: 37396184
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.
Yang Y; Zeng C; Lu X; Song Y; Nie J; Ran R; Zhang Z; He C; Zhang W; Liu SM
Clin Chem; 2019 Nov; 65(11):1414-1425. PubMed ID: 31575611
[TBL] [Abstract][Full Text] [Related]
10. Novel ferroptosis gene biomarkers and immune infiltration profiles in diabetic kidney disease via bioinformatics.
Huang Y; Yuan X
FASEB J; 2024 Jan; 38(2):e23421. PubMed ID: 38198194
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease.
Chen S; Li B; Chen L; Jiang H
BMC Med Genomics; 2023 May; 16(1):90. PubMed ID: 37127580
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning.
Chen Y; Liao L; Wang B; Wu Z
Front Immunol; 2024; 15():1332279. PubMed ID: 38390317
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.
Diao M; Wu Y; Yang J; Liu C; Xu J; Jin H; Wang J; Zhang J; Gao F; Jin C; Tian H; Xu J; Ou Q; Li Y; Xu G; Lu L
Front Endocrinol (Lausanne); 2022; 13():843721. PubMed ID: 35432190
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel key genes and potential candidate small molecule drugs in diabetic kidney disease using comprehensive bioinformatics analysis.
Li B; Ye S; Fan Y; Lin Y; Li S; Peng H; Diao H; Chen W
Front Genet; 2022; 13():934555. PubMed ID: 36035169
[No Abstract] [Full Text] [Related]
19. Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: Evidence from human transcriptomic data and mouse experiments.
Zhong M; Zhu E; Li N; Gong L; Xu H; Zhong Y; Gong K; Jiang S; Wang X; Fei L; Tang C; Lei Y; Wang Z; Zheng Z
Front Endocrinol (Lausanne); 2023; 14():1134325. PubMed ID: 36960398
[TBL] [Abstract][Full Text] [Related]
20. Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease.
Tang YL; Dong XY; Zeng ZG; Feng Z
Medicine (Baltimore); 2020 Jan; 99(1):e18596. PubMed ID: 31895808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
